 |
 |
 |
BRIC is a centre of excellence for biomedical research. The scientists in the centre focus on understanding the molecular mechanisms leading to various diseases, including cancer, CNS-related diseases and metabolic diseases
From banker to top scientist
ERC starting grant to BRIC Group Leader Roger Pocock for his project "Deciphering the microRNA response to hypoxia". Read more...
Cancer drug development - grant to collaborative project
The Danish National Advanced Technology Foundation (Højteknologifonden) has supported a joint project between BRIC Group Leader Kristian Helin and the companies EpiTherapeutics, Nuevolution and ExpreS2ion Biotechnologies. The aim of the project is to develop new drugs against cancer targeting epigenetic enzymes. Read more...
